200,000+ products from a single source!

sales@angenechem.com

Home > Nitro Compounds > 38101-92-7

38101-92-7

38101-92-7 | 2-[(E)-2-(3-nitrophenyl)vinyl]quinoline

CAS No: 38101-92-7 Catalog No: AG00JH1S MDL No:MFCD00024000

Product Description

Catalog Number:
AG00JH1S
Chemical Name:
2-[(E)-2-(3-nitrophenyl)vinyl]quinoline
CAS Number:
38101-92-7
Molecular Formula:
C17H12N2O2
Molecular Weight:
276.2894
MDL Number:
MFCD00024000
IUPAC Name:
2-[(E)-2-(3-nitrophenyl)ethenyl]quinoline
InChI:
InChI=1S/C17H12N2O2/c20-19(21)16-6-3-4-13(12-16)8-10-15-11-9-14-5-1-2-7-17(14)18-15/h1-12H/b10-8+
InChI Key:
URIXDBULDXTIHZ-CSKARUKUSA-N
SMILES:
[O-][N+](=O)c1cccc(c1)/C=C/c1ccc2c(n1)cccc2
NSC Number:
13861

Properties

Complexity:
391  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
276.09g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
276.295g/mol
Monoisotopic Mass:
276.09g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
58.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.3  

Literature

Title Journal
PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcoma. Cancer research 20120901
A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells. Oncology reports 20120301
Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma. PloS one 20120101
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111201
R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis. PloS one 20110101

© 2019 Angene International Limited. All rights Reserved.